Your browser doesn't support javascript.
loading
Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.
Ebata, S; Yoshizaki, A; Fukasawa, T; Nakamura, K; Yamashita, T; Miura, S; Saigusa, R; Ichimura, Y; Takahashi, T; Hirabayashi, M; Taniguchi, T; Akamata, K; Asano, Y; Sato, S.
Afiliação
  • Ebata S; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Yoshizaki A; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Fukasawa T; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Nakamura K; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Yamashita T; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Miura S; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Saigusa R; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Ichimura Y; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Takahashi T; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Hirabayashi M; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Taniguchi T; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Akamata K; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Asano Y; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
  • Sato S; a Department of Dermatology, Faculty of Medicine , University of Tokyo , Tokyo , Japan.
Scand J Rheumatol ; 46(3): 247-252, 2017 05.
Article em En | MEDLINE | ID: mdl-27900875
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Rituximab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Rituximab / Fatores Imunológicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article